QuickVue COVID-19 Test The QuickVue COVID-19 Test is a rapid, qualitative lateral flow immunoassay for detecting SARS-CoV-2 nucleocapsid protein antigens in anterior nasal swab specimens. This CLIA-waived test is designed for home use and provides visual results in approximately 10 minutes. Key Specifications FDA 510(k) cleared for non-prescription home use CLIA Waived classification for simplified testing 10-minute visual read results Lateral flow test strip format Intended for individuals with symptoms within first 5 days of onset For ages 14+ self-testing or adults testing individuals aged 2+ Each test kit includes pre-filled reagent tubes, test strips, swabs, and instructions. Available in multiple packaging configurations to meet different testing needs.